Khorana S - Search Results

1

T-cell involvement in benign phase chronic myelogenous leukemia.

Nogueira-Costa R, Spitzer G, Khorana S, Pham Q, Kantarjian HM, Manning JT, Ordonez NG, Dicke KA. Nogueira-Costa R, et al. Among authors: khorana s. Leuk Res. 1986;10(12):1433-9. doi: 10.1016/0145-2126(86)90010-x. Leuk Res. 1986. PMID: 3099099

2

Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia.

Auber ML, Horwitz LJ, Blaauw A, Khorana S, Tucker S, Woods T, Warmuth M, Dicke KA, McCredie KB, Spitzer G. Auber ML, et al. Among authors: khorana s. Blood. 1988 Jan;71(1):166-72. Blood. 1988. PMID: 2446678 Free article.

3

Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.

Wohllk N, Cote GJ, Bugalho MM, Ordonez N, Evans DB, Goepfert H, Khorana S, Schultz P, Richards CS, Gagel RF. Wohllk N, et al. Among authors: khorana s. J Clin Endocrinol Metab. 1996 Oct;81(10):3740-5. doi: 10.1210/jcem.81.10.8855832. J Clin Endocrinol Metab. 1996. PMID: 8855832

4

Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.

Ventura GJ, Hester JP, Dixon DO, Khorana S, Keating MJ. Ventura GJ, et al. Among authors: khorana s. Hematol Pathol. 1989;3(1):23-8. Hematol Pathol. 1989. PMID: 2745357

5

Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A.

Gagel RF, Cote GJ, Martins Bugalho MJ, Boyd AE 3rd, Cummings T, Goepfert H, Evans DB, Cangir A, Khorana S, Schultz PN. Gagel RF, et al. Among authors: khorana s. J Intern Med. 1995 Oct;238(4):333-41. doi: 10.1111/j.1365-2796.1995.tb01207.x. J Intern Med. 1995. PMID: 7595169

6

Mutational analysis of the GDNF/RET-GDNFR alpha signaling complex in a kindred with vesicoureteral reflux.

Shefelbine SE, Khorana S, Schultz PN, Huang E, Thobe N, Hu ZJ, Fox GM, Jing S, Cote GJ, Gagel RF. Shefelbine SE, et al. Among authors: khorana s. Hum Genet. 1998 Apr;102(4):474-8. doi: 10.1007/s004390050724. Hum Genet. 1998. PMID: 9600247

7

A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.

Dang GT, Cote GJ, Schultz PN, Khorana S, Decker RA, Gagel RF. Dang GT, et al. Among authors: khorana s. Mol Cell Probes. 1999 Feb;13(1):77-9. doi: 10.1006/mcpr.1998.0220. Mol Cell Probes. 1999. PMID: 10024437

8

Identification of a polymorphism in exon 11 of the RET protooncogene.

Bugalho MJ, Cote GJ, Khorana S, Schultz PN, Gagel RF. Bugalho MJ, et al. Among authors: khorana s. Hum Mol Genet. 1994 Dec;3(12):2263. doi: 10.1093/hmg/3.12.2263-a. Hum Mol Genet. 1994. PMID: 7881435 No abstract available.

9

Direct sequencing of PCR products in agarose gel slices.

Khorana S, Gagel RF, Cote GJ. Khorana S, et al. Nucleic Acids Res. 1994 Aug 25;22(16):3425-6. doi: 10.1093/nar/22.16.3425. Nucleic Acids Res. 1994. PMID: 7915835 Free PMC article.

10

Evidence for somatic cell expression of the c-mos protein [corrected].

Herzog NK, Ramagli LS, Khorana S, Arlinghaus RB. Herzog NK, et al. Among authors: khorana s. Oncogene. 1989 Nov;4(11):1307-15. Oncogene. 1989. PMID: 2530484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters